IDL Diagnostics AB (publ) (OM: IDLDX)
Health Care · Life Sciences Tools & Services · SE
Skr0.41
+9.31% today · -12.6% 1Y
IDL Diagnostics AB (publ) (OM: IDLDX) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $10.00M and employs 25 people.
Over the last twelve months the share price has lost 12.6%, trading between 0.25 and 0.53.
Tweenvest scores IDL Diagnostics AB (publ) across four factors: quality 56/100, value 74/100, growth 100/100. Its strongest factor is growth.
IDLDX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.00M
- Revenue (TTM)
- $6.08M
- P/E
- —
- EPS
- -0.06
- Dividend yield
- —
- Beta (5Y)
- 0.95
- 52-week high
- Skr0.53
- 52-week low
- Skr0.25
- Avg volume (3M)
- —
- Shares outstanding
- 230.36M
- Employees
- 25
- Next earnings
- —
About IDL Diagnostics AB (publ)
Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops and markets diagnostic tests aimed at detecting cancer and bacterial infections within the Swedish market. Its product portfolio includes UBC Rapid, a point-of-care solution for both diagnosing and tracking bladder cancer; AroCell TK 210 ELISA, utilized as a biomarker for identifying tumor cells; and TUBEX TF, an in vitro diagnostic tool for pinpointing acute typhoid fever. Formerly operating as AroCell AB (publ), the company is scheduled to adopt the name IDL Diagnostics AB (publ) in May 2025. Established in 2000, its operations are headquartered in Stockholm, Sweden.
- ISIN
- SE0003883990
- Founded
- 2000
- Listed since
- May 19, 2025
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.26B | $633.71 | +0.89% |
| Danaher CorporationNYSE: DHR | $151.82B | $215.36 | -0.28% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $71.35B | CN¥161.00 | +3.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.65B | CHF587.80 | -1.01% |
| Agilent Technologies, Inc.NYSE: A | $43.71B | $155.08 | +0.20% |
| IQVIA Holdings Inc.NYSE: IQV | $42.70B | $261.51 | +0.81% |
| Waters CorporationNYSE: WAT | $40.72B | $414.17 | -0.07% |
Figures last refreshed Aug 18, 2026.